Skip to main content
Clinical Trials/NCT05843487
NCT05843487
Active, not recruiting
Not Applicable

Association Between Carotid Plaque Length and Cardiovascular Outcomes

Changhai Hospital5 sites in 1 country3,000 target enrollmentJanuary 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Changhai Hospital
Enrollment
3000
Locations
5
Primary Endpoint
major adverse cardiovascular events
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

This multicenter study involved 5 hospitals (Changhai Hospital; Yueyang Hospital of Shanghai University of Traditional Chinese Medicine; Gongli Hospital; Putuo Hospital of Shanghai University of Traditional Chinese Medicine; No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi). The study enrolled 5000 consecutive patients without known CAD who underwent first coronary angiography for stable chest pain and carotid ultrasound was performed during hospitalization from January 2017 through December 2018.

Detailed Description

Patients who had obstructive CAD (defined as ≥50% luminal stenosis) confirmed by coronary angiography and who underwent carotid scanning were included in the final analysis.Carotid ultrasonography was performed simultaneously, and carotid intima-media thickness (IMT), maximum thickness and length of all plaques were measured.The incidence of major adverse cardiovascular events was recorded during follow-up.

Registry
clinicaltrials.gov
Start Date
January 1, 2017
End Date
December 31, 2030
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients who underwent coronary angiography for stable chest pain and carotid ultrasound simultaneously;
  • Patients with obstructive CAD (≥50% coronary stenosis);

Exclusion Criteria

  • \<18 years of age;
  • previous carotid surgery or significant carotid artery disease;
  • prior stroke or transient ischemic attack;
  • previously documented CAD (including history of myocardial infarction, acute coronary syndrome, or coronary revascularization);

Outcomes

Primary Outcomes

major adverse cardiovascular events

Time Frame: 3 years

cardiovascular death, myocardial infarction, ischemic stroke and coronary revascularization

Secondary Outcomes

  • cardiovascular death(3 years)
  • ischemic stroke(3 years)
  • heart failure(3 years)
  • all-cause death(3 years)
  • myocardial infarction(3 years)
  • coronary artery revascularization(3 years)

Study Sites (5)

Loading locations...

Similar Trials